The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: A randomized, cross-over trial

Neurogastroenterology and Motility

Volumn 24, Issue 6, 2012, Pages

  Orr, W C ^a,b   Goodrich, S ^a   Wright, S ^a   Shepherd, K ^a   Mellow, M ^c  

^a Lynn Institute for Healthcare Research   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c INTEGRIS BAPTIST MEDICAL CENTER   (United States)

Author keywords

Gastroesophageal reflux; PH monitoring; Polysomnography; Sleep quality

Indexed keywords

BACLOFEN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; SLEEP QUALITY; SLEEP TIME; SLEEP WAKING CYCLE; WAKEFULNESS;

ADULT; AGED; BACLOFEN; CROSS-OVER STUDIES; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; POLYSOMNOGRAPHY; QUESTIONNAIRES; SLEEP; TREATMENT OUTCOME;

EID: 84861194666     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01900.x     Document Type: Article

References (30)

1. Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABAB agonist baclofen on 24hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003; 52: 464-70.
2. Lidums I, Lehmann A, Checklin H, Dent J, Holloway RH. Control of transient lower esophageal sphincter relaxations and reflux by the GABAB agonist baclofen in normal subjects. Gastroenterol 2000; 118: 7-13.
3. Vela MF, Tutuian R, Katz PO, Castell DO. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedence and pH. Aliment Pharmacol Ther 2003; 17: 243-51.
4. Zhang Q, Lehmann A, Rigda R, Dent J, Holloway RH. Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease. Gut 2002; 50: 19-24.
5. Van Herwaarden MA, Samsom M, Rydholm H, Smout AJPM. The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Therap 2002; 16: 1655-62.
6. Grossi L, Spezzaferro M, Sacco LF, Marzio L. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Neurogastroenterol Motil 2008; 20: 760-66.
7. Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep 2008; 10: 252-57.
8. Holloway RH, Dent J, Narielvala F, Mackinnon AM. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996; 38: 649-54.
9. Vela MF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterol 2001; 120: 1599-606.
10. Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 2004; 27: 799-818.
11. Farup C, Kleinman L, Sloan S et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161: 45-52.
12. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003; 98: 1487-93.
13. Orr WC. Review article: sleep-related gastro-oesophageal reflux as a distinct clinical entity. Aliment Pharmacol Ther 2010; 31: 47-56.
14. Schindlebeck NE, Heinrich C, Konig A, Dendorfer A, Page F, Muller-Lissner SA. Optimal thresholds, sensitivity and specificity of long term pH-metry for the detection of gastroosophageal reflux disease. Gastroenterol 1987; 93: 85-90.
15. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
16. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5.
17. Carlsson R, Dent J, Bolling-Sternevald E et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998; 33: 1023-9.
18. Yuen K, Frystyk J, Margot U, Fryklund L, Dunger D. Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young health adults. J Clin Endocrinol Metab 2004; 89: 3956-64.
19. Freidin N, Fisher MJ, Taylor W et al. Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut 1991; 32: 1275-9.
20. Dent J, Dodds WJ, Friedman RH et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980; 65: 256-67.
21. Manfridi A, Brambilla D, Mancia M. Sleep is differently modulated by basal forebrain GABAA and GABAB receptors. Am J Physiol Regul Integr Comp Physiol 2001; 281: R170-R75.
22. Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur Respir J 1995; 8: 230-34.
23. Guilleminault C, Flagg W. Effect of baclofen on sleep-related periodic leg movements. Ann Neurol 1984; 15: 234-39.
24. Buscemi N, Vandermeer B, Friesen C et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007; 22: 1335-50.
25. Mainie I, Tutuian R, Shay S et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006; 55: 1398-402.
26. Koek GH, Sifrim D, Lerut T, Janssens J, Tack J. Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003; 52: 1397-402.
27. Penzel T, Becker HF, Brandenburg U, Labunski T, Pankow W, Peter JH. Arousal in patients with gastro-oesophageal reflux and sleep apnoea. Eur Respir J 1999; 14: 1266-70.
28. Dent J, Holloway RH, Toouli J, Dodds WJ. Mechanisms of lower esophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux. Gut 1988; 29: 1020-28.
29. Johnson DA, Orr WC, Crawley JA et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol 2005; 100: 1914-22.
30. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterol 2002; 123: 461-7.